📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

A Polytherapy Strategy Using Vincristine and ALK Inhibitors to Sensitise EML4-ALK-Positive NSCLC. (2022)

First Author: Sampson J

Attributed to: A Multi-User Flow Cytometry Facility for the Biosciences in Leeds funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/cancers14030779

PubMed Identifier: 35159046

Publication URI: http://europepmc.org/abstract/MED/35159046

Type: Journal Article/Review

Volume: 14

Parent Publication: Cancers

Issue: 3

ISSN: 2072-6694